Invivyd (IVVD) Competitors

Invivyd (NASDAQ:IVVD) and Heron Therapeutics (NASDAQ:HRTX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, institutional ownership, profitability, valuation, dividends, community ranking, earnings and risk.

Which has more volatility & risk, IVVD or HRTX?

Invivyd has a beta of 0.09, meaning that its stock price is 91% less volatile than the S&P 500. Comparatively, Heron Therapeutics has a beta of 1.55, meaning that its stock price is 55% more volatile than the S&P 500.

Does the media prefer IVVD or HRTX?

In the previous week, Invivyd had 6 more articles in the media than Heron Therapeutics. MarketBeat recorded 8 mentions for Invivyd and 2 mentions for Heron Therapeutics. Heron Therapeutics' average media sentiment score of 1.72 beat Invivyd's score of 0.46 indicating that Heron Therapeutics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Invivyd	0 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Heron Therapeutics	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Does the MarketBeat Community prefer IVVD or HRTX?

Heron Therapeutics received 643 more outperform votes than Invivyd when rated by MarketBeat users. However, 85.71% of users gave Invivyd an outperform vote while only 68.83% of users gave Heron Therapeutics an outperform vote.

Company	Underperform	Outperform
Invivyd	Outperform Votes 24 85.71%	Underperform Votes 4 14.29%
Heron Therapeutics	Outperform Votes 667 68.83%	Underperform Votes 302 31.17%

Do institutionals and insiders hold more shares of IVVD or HRTX?

70.4% of Invivyd shares are held by institutional investors. Comparatively, 80.0% of Heron Therapeutics shares are held by institutional investors. 17.9% of Invivyd shares are held by insiders. Comparatively, 5.8% of Heron Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Is IVVD or HRTX more profitable?

Invivyd has a net margin of 0.00% compared to Heron Therapeutics' net margin of -20.31%. Heron Therapeutics' return on equity of 0.00% beat Invivyd's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Invivyd	N/A	-155.33%	-114.88%
Heron Therapeutics	-20.31%	N/A	-12.72%

Do analysts rate IVVD or HRTX?

Invivyd presently has a consensus target price of $7.89, suggesting a potential upside of 1,214.58%. Heron Therapeutics has a consensus target price of $5.67, suggesting a potential upside of 150.74%. Given Invivyd's stronger consensus rating and higher probable upside, research analysts clearly believe Invivyd is more favorable than Heron Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Invivyd	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	3.20
Heron Therapeutics	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has higher valuation and earnings, IVVD or HRTX?

Heron Therapeutics has higher revenue and earnings than Invivyd. Heron Therapeutics is trading at a lower price-to-earnings ratio than Invivyd, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Invivyd	$25.38M	2.84	-$198.64M	-$1.44	-0.42
Heron Therapeutics	$144.29M	2.39	-$110.56M	-$0.09	-25.11

Summary

Invivyd beats Heron Therapeutics on 10 of the 19 factors compared between the two stocks.